These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9039547)

  • 1. Prophylaxis against Mycobacterium avium-intracellulare complex infections in human immunodeficiency virus-infected patients.
    Nightingale SD
    Infection; 1997; 25(1):67-70. PubMed ID: 9039547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing disseminated Mycobacterium avium complex disease in patients infected with human immunodeficiency virus.
    Ostroff SM; Spiegel RA; Feinberg J; Benson CA; Horsburgh CR
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S72-6. PubMed ID: 8547516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of utilization of rifabutin for prophylaxis of Mycobacterium avium complex among patients with advanced human immunodeficiency virus disease in a community setting.
    Mandigo K; Hogg RS; Phillips P; Barber C; Le T; Bessuille E; Black W; O'Shaughnessy MV; Schechter MT; Montaner JS
    Tuber Lung Dis; 1996 Jun; 77(3):233-8. PubMed ID: 8758106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifabutin prophylaxis against Mycobacterium avium complex infections in HIV-infected patients: impact on the incidence of campylobacteriosis.
    Pulik M; Genet P; Leturdu F; Lionnet F; Louvel D; Touahri T
    AIDS Patient Care STDS; 1999 Aug; 13(8):467-72. PubMed ID: 10800525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
    Cohn DL
    Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?
    Yangco BG; Buchacz K; Baker R; Palella FJ; Armon C; Brooks JT;
    AIDS Patient Care STDS; 2014 Jun; 28(6):280-3. PubMed ID: 24833016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?
    Lange CG; Woolley IJ; Brodt RH
    Drugs; 2004; 64(7):679-92. PubMed ID: 15025543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis.
    Bayoumi AM; Redelmeier DA
    AIDS; 1998 Aug; 12(12):1503-12. PubMed ID: 9727572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
    Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
    MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease.
    Dautzenberg B
    Drugs; 1997; 54 Suppl 2():1-7; discussion 28-9. PubMed ID: 9358194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis of Mycobacterium avium complex bacteremia in patients with AIDS.
    Gordin F; Masur H
    Clin Infect Dis; 1994 Apr; 18 Suppl 3():S223-6. PubMed ID: 8204774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis.
    Jung Y; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Oh MD
    Int J STD AIDS; 2017 Dec; 28(14):1426-1432. PubMed ID: 28592210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin in the prophylaxis of opportunistic infections in AIDS.
    McCutchan JA
    Int J STD AIDS; 1996; 7 Suppl 1():34-7. PubMed ID: 8652726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease.
    Hewitt RG; Papandonatos GD; Shelton MJ; Hsiao CB; Harmon BJ; Kaczmarek SR; Amsterdam D
    AIDS; 1999 Jul; 13(11):1367-72. PubMed ID: 10449290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mycobacterium avium complex disease in HIV seropositive patients: incidence and risk factors before and after the introduction of highly active antiretroviral treatments. Clinical Epidemiology Group of the Information and Care Center for Human Immunodeficiency].
    Mary-Krause M; Rabaud C; Jouan M; Obadia M; de la Blanchardière A; Raffi F; May T
    Pathol Biol (Paris); 2000 Jun; 48(5):495-504. PubMed ID: 10949848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and bacteriologic impact of rifabutin prophylaxis for Mycobacterium avium complex infection in patients with human immunodeficiency virus infection.
    Maslo C; Buré-Rossier A; Girard PM; Gholizadeh Y; Lebrette MG; Rozenbaum W
    Clin Infect Dis; 1997 Mar; 24(3):344-9. PubMed ID: 9114183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
    Uthman MM; Uthman OA; Yahaya I
    Cochrane Database Syst Rev; 2013 Apr; (4):CD007191. PubMed ID: 23633339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
    N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the quality of life associated with rifabutin prophylaxis for Mycobacterium avium complex in persons with AIDS: combining Q-TWiST and multiattribute utility techniques.
    Revicki DA; Simpson KN; Wu AW; LaVallee RL
    Qual Life Res; 1995 Aug; 4(4):309-18. PubMed ID: 7550179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Mycobacterium avium complex prophylaxis on the incidence of mycobacterial infections and transfusion-requiring anemia in an HIV-positive population.
    Kravcik S; Toye BW; Fyke K; Hawley-Foss N; Fillion D; Yurack JA; Cameron DW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep; 13(1):27-32. PubMed ID: 8797683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.